Rarity Bioscience (private company)
See something wrong or missing? Let us know
Offices:Uppsala
Industry:BiotechHealth services
Business model:B2B
Rarity Bioscience is a Swedish biotech company that developed a new ultra-sensitive technology for detection of mutations in liquid biopsies, called superRCA, tailored for detection of cancer relapse.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 10.08M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Rarity Bioscience
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
53%
|
|
![]() |
Acesion Pharma
53%
|
|
![]() |
Achilles Therapeutics
53%
|
|
![]() |
Aprea Therapeutics
53%
|
|
![]() |
Arthex Biotech S.L.
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
Biograil
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|